Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05132647
Other study ID # P0030822
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 1, 2021
Est. completion date June 30, 2022

Study information

Verified date October 2021
Source The Hong Kong Polytechnic University
Contact Stanley J Winser, PhD
Phone 27666746
Email stanley.j.winser@polyu.edu.hk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cerebellar ataxia (CA) is a collection of signs and symptoms caused by cerebellar dysfunction, which can be the result of different disease processes including hereditary and acquired conditions. High incidence of falls is reported in people with CA due to poor balance while walking. Therefore, it is crucial to assess the balance of people with CA to identify potential fallers. There are some clinical tests commonly used for assessing the balance of people with CA, including both generic measures of balance and ataxia-specific rating scales. The current best balance outcome measures for CA includes Berg Balance Scale (BBS), Timed Up and Go test (TUG), and the balance related items in Scale for the assessment and rating of ataxia (SARA). TUG is commonly used in clinical settings for the assessment of mobility and fall risk of individuals. However, a study done by Winser et. al (2017) found that the correlation between TUG and ataxia rating scales (SARA and ICARS) is only moderate. This indicates that the gait speed and functional mobility findings of TUG might not truly reflect the balance deficits of CA. Therefore, our study will develop a modified TUG for the assessment of balance in people with CA. Circular TUG (cTUG) is a modified version of the standard TUG. cTUG is an equilibrium test that challenges subjects' ability to maintain balance in response to the constant change in direction of walking. In cTUG, the subject walks a semi-circular pathway instead of a straight line. Walking in a circular pathway targets at challenging the coordination of people with CA as walking in a circle requires constant change in directions and correction after feedback. It is speculated that the cTUG will have better accuracy in predicting the balance and falls risk among people with CA. We will target at recruiting 30 healthy volunteers and 30 individuals with cerebellar ataxia. Besides the cTUG we will also assess disease severity of ataxia using the Scale for the Assessment and Rating of Ataxia (SARA), balance using the Berg Balance Scale, Timed Up and Go test, Sensory Organization test, Limits of Stability test and functional independence using the Barthel Index. For validation of the cTUG, two types of reliability will be examined, including intra-rater reliability and interrater reliability and four types of validity will be assessed, including concurrent validity, convergent validity, discriminant validity, and external validity.


Description:

Background What is Cerebella ataxia (CA)? Cerebellar ataxia (CA) is a collection of signs and symptoms caused by cerebellar dysfunction, which can be the result of different disease processes including hereditary and acquired conditions (Hadjivassiliou et al., 2017). Common clinical presentation of CA patients includes balance and gait dysfunction, dysmetria, dyssynergia, dysarthria and dysdiadochokinesia (Diener & Dichgans, 1992). People with CA usually walks with increased step width, increased foot rotation angles and reduced cadence, which is related to impaired balance (Stolze et al., 2002). Marsden & Harris (2011) suggested that the high incidence of falls in people with CA may be related to their poor balance in walking. Therefore, it is crucial to assess the balance of people with CA to identify potential fallers. Current balance assessments and drawbacks of TUG There are some clinical tests commonly used for assessing the balance of people with CA, including both generic measures of balance and ataxia-specific rating scales. The current best balance outcome measures for CA includes Berge Balance Scale (BBS), Timed Up and Go test (TUG), and the balance related items in Scale for the assessment and rating of ataxia (SARA) (Winser et al., 2015). TUG is commonly used in clinical settings for the assessment of mobility and fall risk of individuals (Dawson et al., 2018). However, a study done by Winser et. al (2017) found that the correlation between TUG and ataxia rating scales (SARA and ICARS) is only moderate. This indicates that the gait speed and functional mobility findings of TUG might not truly reflect the balance deficits of CA. Therefore, in order to bridge this gap, our study will develop a modified TUG for the assessment of balance in people with CA. The specific objectives of this study will be to examine the reliability, validity of the modified TUG for identifying the balance and fall risk of cerebellar ataxia patients. Circular TUG: A modification that might suit CA Circular TUG (cTUG) is a modified version of the standard TUG. cTUG is an equilibrium test that challenges subjects' ability to maintain balance in response to constant change in direction of walking. In standard TUG, the person gets up from an armchair, walks three meters in a straight pathway, then turn 180 degrees and walks back to the chair to sit down (Podsiadlo & Richardson, 1991b). However, in cTUG, the subject walks a semi-circular pathway instead of a straight line. Walking in a circular pathway targets at challenging the coordination of people with CA as walking in a circle requires constant change in directions and correction after feedback (Goodworth et al., 2012). Moreover, walking in a circle is more difficult for patients with CA as it increases the role of the cerebellum for trunk and foot control during curvilinear locomotion (Goodworth et al., 2012). Therefore, it is speculated that the cTUG will have better accuracy in predicting the balance and falls risk among people with CA. Objectives and hypothesis The overall aim of this study is to develop and test the psychometric properties of the cTUG in assessing balance and falls risk prediction among individuals with cerebellar ataxia and age-matched healthy volunteers. To address this objective, we have the following specific objectives. 1. Develop the cTUG and record the normative scores of the newly developed scale among healthy volunteers and mean scores among individuals with cerebellar ataxia. 2. Examine the test-retest, inter-rater and intra-rater reliability of the cTUG among healthy volunteers and individuals with cerebellar ataxia. 3. Examine the concurrent validity, convergent validity, discriminant validity, and external validity of the cTUG among individuals with cerebellar ataxia. For validity, concurrent validity, convergent validity, discriminant validity, and external validity will be assessed. Based on the findings of a previous study that reported a moderate negative correlation (-0.62) between standard TUG and Berg Balance scale (BBS) (Cattaneo et al., 2006), we hypothesize a moderate to strong negative correlation between cTUG and BBS. Moreover, based on the findings of a previous study that reported a moderate positive correlation (0.584) between standard TUG and Scale for the Assessment and Rating of Ataxia (SARA) (Choi et al., 2018), we hypothesize a moderate to strong positive correlation between cTUG and the balance component SARA. In addition, based on the findings of a previous study that reported a positive correlation between TUG and Modified Clinical Test of Sensory Organization and Balance (m-CTSIB) and a negative correlation between TUG and Limit of Stability (LOS) (Dawson et al., 2018), we hypothesize a positive correlation between cTUG and Sensory Organization Test (SOT), and a negative correlation between cTUG and LOS. Besides, based on the findings of a previous study that reported a moderate negative correlation (-0.78) between standard TUG and Barthel Index (BI) (Podsiadlo & Richardson, 1991b), we hypothesize a moderate negative correlation between cTUG and BI. For reliability, intra-rater reliability and inter-rater reliability will be assessed. Repeat assessment by the same investigator will be used to estimate intra-rater reliability and repeat assessments by 2 different investigators will be used to estimate inter-rater reliability. All the assessments will be completed on the same day with each assessment conducted with 1 hour rest period. Ethics will be obtained through the Human Subjects Ethics Sub-committee of the Hong Kong Polytechnic University and trial registration will be done through the Clinical Trials Registry. Participants with a confirmed diagnosis of CA of any or unknown cause will be recruited through the Hong Kong Spinocerebellar Ataxia Association (HKSCAA) and one group of age-matched healthy volunteers will be recruited from the Hong Kong PolyU campus. We will post advertisement flyers at the HK PolyU campus and at the HKSCAA for recruiting potential participants. In addition, for recruiting participants with cerebellar ataxia, an advertisement flyer will be posted on the monthly newsletter of the HKSCAA. The specific criteria for recruitment are reported elsewhere.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date June 30, 2022
Est. primary completion date May 30, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - CA patients (hereditary, degenerative or acquired underlying cause) - ambulatory - age 18-65 - able to walk independently with or without assistive walking device for at least 10m Exclusion Criteria: - CA patients who require hand held support during walking - CA patients with severe visual impairment - Expanded Disability Status Scale (EDSS) score >6.5 - Refuse to reveal personal information - CA patients with other associated neurological conditions that does not result in ataxia features - Poor cognition or unable to follow the instructions Healthy adults: Both genders aged 18 to 65 who are ambulant with or without assistive device for walking.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Hong Kong The Hong Kong Polytechnic University Hung Hom Kowloon

Sponsors (1)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Circular TUG (cTUG) Circular TUG (cTUG) is a modified version of the standard TUG. cTUG is an equilibrium test that challenges subjects' ability to maintain balance in response to constant change in direction of walking. In standard TUG, the person gets up from an armchair, walks three meters in a straight pathway, then turn 180 degrees and walks back to the chair to sit down (Podsiadlo & Richardson, 1991b). However, in cTUG, the subject walks a semi-circular pathway instead of a straight line. Baseline (T1), Day 1 (T2) and Day 1 (T3)
Secondary Scale for the Assessment and Rating of Ataxia (SARA) The Scale for the Assessment and Rating of Ataxia (SARA) is a measure to assess the severity of cerebellar ataxia. There are total of 8 items: gait, stance, sitting, speech disturbance, finger chase, nose-finger test, fast alternating hand movement and heel-shin slide. The total score ranges from 0 to 40, which indicates no ataxia to severe ataxia. SARA has high inter-rater reliability (ICC = 0.98) and high test-retest reliability (ICC = 0.90) in assessing cerebellar ataxia patients. Internal consistency is high as indicated by Cronbach's a of 0.94 (Schmitz-Hubsch et al., 2006). Assessment 1 day 1
Secondary Berg Balance Scale (BBS) Berg Balance Scale (BBS) measures the ability in maintaining balance during tasks. The scale consists of 14 items, requiring patients to maintain different positions for specific durations. Each item is rated from 0 to 4, from lowest ability to highest ability. The time and quality in maintaining positions are assessed. The maximum score is 56. Score of less than 45 indicates higher fall risk (Katherine et al., 1992). The test has good inter-rater reliability (ICC = 0.96) and high test-retest reliability (ICC = 0.94) (Cattaneo et al., 2007). Assessment 1 day 1
Secondary The timed up and go test The timed up and go test is a test to quantify the functional mobility by balance, gait speed and functional capacity. The subject is timed while asked to stand up from a chair, walks 3 meters, turns and walks back and sits down again. Those who takes more than 30 seconds to complete the test are considered having poor balance and require assistance for many mobility tasks. Those completed the test in less than 10 seconds are considered very independent in mobility tasks (Podsiadlo & Richardson, 1991a). Assessment 1 on Day 1, Assessment 2 on day 1 and Assessment 3 on day 2
Secondary Sensory organization test (SOT) Sensory organization test (SOT) is an objective evaluation on postural stability under different sensory conditions. The test is performed with the Bertec System. Subjects are challenged to stand unsupported under six sensory scenarios, with different visual, somatosensory and vestibular inputs. There are three trials lasting for 20 seconds in each scenario. Equilibrium score in each scenario and the composite equilibrium score are assessed. The equilibrium score provides quantitative evaluation on subjects' postural sway under different sensory conditions. Composite equilibrium score shows subjects' average performance over the trials. The score of subjects is compared to the normative data in the software database. Results falling outside normal value indicates abnormal sway and shows difficulty in incorporating sensory information for balance control. (Bertec corporation, 2014). Assessment 1 day 1
Secondary Limit of Stability (LOS) Limit of Stability (LOS) is an objective balance assessment by assessing the ability to displace centre of gravity in different directions without losing balance. The test is performed with the Bertec System. Subjects are assessed in eight directions and their centre of gravity is traced during movement. The directional control (DCL), reaction time (RT) and maximum excursion (MXE) are assessed. Directional control is the measurement of how much subjects move towards the target direction. Reaction time is the time taken for subjects to respond to the command of moving towards the target. Maximum excursion is measurement of the extent that subjects lean during trials. The score of subjects is compared to the normative data in the software database. Result falling outside the normal value indicates restricted stability limit and an increased risk of falling. (Bertec corporation, 2014). Assessment 1 day 1
Secondary Barthel Index The Barthel index (BI) is an ordinal scale for measuring performance in activities of daily living (ADL). There are a total of 10 variables under ADL and mobility, each values a given number of points. Higher points indicate a greater degree of independence (O'Sullivan et al., 2019). Assessment 1 day 1
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04677920 - The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology N/A
Active, not recruiting NCT03312920 - Investigating Memory Retrieval Improvement in Healthy Subjects N/A
Completed NCT03309072 - Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task N/A
Completed NCT03289832 - Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin N/A
Enrolling by invitation NCT06133530 - Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica N/A
Completed NCT05141903 - Dietary Supplement With and Without a Probiotic and/or Antibiotic
Completed NCT01689259 - Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults Phase 1
Completed NCT01187875 - Resistant Starch and Satiety Phase 0
Completed NCT03312699 - Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort Phase 1
Completed NCT03319134 - Investigating the Neural Correlates in Memory Retrieval After HD-tDCS N/A
Recruiting NCT04104360 - Galacto-oligosaccharides and Intestinal Activity N/A
Completed NCT03228693 - Gene Expression and Biomarker Profiling of Keloid Skin N/A
Completed NCT04146532 - Aspirin Effects on Emotional Reactions Early Phase 1
Completed NCT04206293 - A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers N/A
Recruiting NCT06011018 - Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke N/A
Completed NCT05093205 - STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS Phase 1
Completed NCT04596709 - Investigation of Blood Glucose and Insulin Response After Intake of Vitalose N/A
Completed NCT04272450 - Respiratory Muscle Strength in Different Age Groups
Completed NCT02044679 - Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions N/A
Completed NCT01402973 - Pilot Study of a Dietary Intervention Based Upon Advanced Glycation End Products N/A